Breathe: Slow Paced Breathing to Lower Blood Pressure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00328016|
Recruitment Status : Completed
First Posted : May 19, 2006
Results First Posted : July 2, 2017
Last Update Posted : July 2, 2017
|Condition or disease||Intervention/treatment|
|High Blood Pressure||Behavioral: Guided Breathing Device: RESPeRATE|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||44 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Respiratory Adaptations to Behavioral Interventions in Elevated Blood Pressure|
|Study Start Date :||April 2006|
|Primary Completion Date :||December 2009|
|Study Completion Date :||December 2009|
Experimental: Device Guided Breathing
Individual breathing rate was determined from an expandable band around the torso connected to a commercially available device (RESPeRATE, Lod, Israel) that presented distinctive tones via earphones.
The participant will be trained to perform a guided breathing task that involves a chest expansion sensor, battery-powered microcomputer, and earphones
Placebo Comparator: Control Group
Control group were instructed to sit in the same manner passively attend to their breathing, and silently repeat 'one' during each exhalation. If other thoughts came to mind, they were instructed to calmly attend to their breathing.
Behavioral: Guided Breathing
The participant will engage in daily 15 min sessions of meditative relaxation that involves quiet attention to breathing pattern with no attempt to manipulate breathing pattern
- Breathing Rate [ Time Frame: After 15 minutes of guided breathing or control task ]Breathing rate was monitored continuously via inductive plethysmography.
- Minute Ventilation [ Time Frame: After 15 minutes of guided breathing or control task ]Minute Ventilation was continuously monitored via inductive plethysmography
- End Tidal CO2 (PetCO2) [ Time Frame: After 15 minutes of guided breathing or control task ]End tidal CO2 was monitored continuously using a respiratory gas monitor
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00328016
|United States, Maryland|
|NIA Clinical Research Unit|
|Baltimore, Maryland, United States, 21225|
|Principal Investigator:||William B. Ershler, M.D.||NIA, Clinical research Unit|